Prince Edward Island

Prince Edward Island (PEI) has emerged as a powerhouse in the global life sciences ecosystem, renowned for its collaborative PEI Bioscience Cluster and expertise in biomanufacturing and natural product chemistry.

The province is a recognized leader in pharmaceutical development, specifically in the production of human, animal and fish health products, including advanced biologics and mRNA vaccines.

Biotechnology firms thrive here, supported by the state-of-the-art BioAccelerator facility, which offers 60,000 square feet of lab space and pilot plant suites for process optimization.

In the medical device and diagnostics sector, PEI hosts world-class manufacturers like Sekisui Diagnostics, contributing to a robust healthcare innovation landscape that integrates digital health strategies and AI-driven analytics.

Academic excellence is anchored by the University of Prince Edward Island (UPEI) and the Atlantic Veterinary College, which drive high-impact academic research in biomedical genetics and more.

PEI’s bioscience sector also benefits from the Canadian Alliance for Skills and Training in Life Sciences (CASTL), providing a specialized workforce for contract manufacturing organizations (CMOs).

This thriving hub offers global life sciences companies a competitive advantage through strategic R&D incentives and a world-class talent pool of chemists and biologists.

With over 60 companies driving significant export revenue, Prince Edward Island continues to scale as a premier destination for life sciences investment and commercialization.